Abstract

e20735 Background: Empegfilgrastim is an innovator drug product of pegylated G-CSF indicated for prophylaxis of neutropenia in patients receiving myelosuppressive chemotherapy. Methods: Objective w...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Trends in the use of primary prophylactic colony-stimulating factors and neutropenia-related hospitalization in elderly cancer patients receiving myelosuppressive chemotherapy in the USA: 1995-2015.
Shuling Li ... Prasad L Gawade
Supportive Care Cancer | VOL. 28
Shuling Li, et. al.Shuling Li ... Prasad L Gawade
17 Oct 2019
Trends in use of primary prophylactic colony stimulating factors and neutropenia-related hospitalization in commercially insured patients receiving myelosuppressive chemotherapy in the United States: 2005-2017.
Jennifer R Schenfeld ... Shuling Li
Journal of Oncology Pharmacy Practice | VOL. 27
Jennifer R Schenfeld, et. al.Jennifer R Schenfeld ... Shuling Li
23 Apr 2020
Abstract OT1-05-01: The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies
Reshma Mahtani ... Prasad Gawade
American Journal of Cancer | VOL. 80
Reshma Mahtani, et. al.Reshma Mahtani ... Prasad Gawade
14 Feb 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.
Pere Gascón ... Jin-Hyoung Kang
Journal of Thoracic Oncology | VOL. 15
Pere Gascón, et. al.Pere Gascón ... Jin-Hyoung Kang
16 Oct 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma.
Alain P Algazi ... Suzanne Dufault
Journal of Clinical Oncology | VOL. 42
Alain P Algazi, et. al.Alain P Algazi ... Suzanne Dufault
01 Jul 2024
Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
-
Journal of Clinical Oncology | VOL. 42
--
01 Jul 2024
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.
Freek R Van ‘T Land ... Casper H.J Van Eijck
Journal of Clinical Oncology | VOL. -
Freek R Van ‘T Land, et. al.Freek R Van ‘T Land ... Casper H.J Van Eijck
01 Jul 2024
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. -
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
28 Jun 2024
View more papers